New diabetes pill XW014 enters first human safety tests
Disease control
Completed
This early-stage study tested an experimental oral drug called XW014 in 127 healthy volunteers and people with type 2 diabetes. The main goal was to check safety and how the body processes the drug, including the effect of food. Researchers gave single or multiple doses to find t…
Phase: PHASE1 • Sponsor: Sciwind Biosciences USA Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC